Company intelligence / Profile preview

WinShore Capital

New York City, New York, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

WinShore Capital is a small private investment management firm headquartered in New York City with approximately $1–$5 million in revenue and fewer than five employees. Founded in 2019, it specializes in alternative investments and seeks out undervalued opportunities overlooked by other investors. There is no evidence that it operates within the life sciences or healthcare sectors as its core business.

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships identified

Beyond the preview

Go deeper on WinShore Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WinShore Capital.

Explore the full profile